This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

Following the presentation titled ‘Discovering Targeted Glue™ degraders with Amphista's Eclipsys® platform’, Simon Gilbert, PhD, Presenting Author and Associate Director Discovery Biology at Amphista ...

Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate ...

The Swiss company Novartis, represented by Greenberg Traurig, filed its lawsuit against Incyte in January 2020. According to that complaint, the two companies entered into a contract in 2009 ...

Novartis AG blocked MSN Laboratories Pvt. Ltd.’s attempt to launch a copy of its blockbuster Entresto before July 16, as a ...

For what brand would not want its logo to be emphasized? And if a company’s goal is to use its logo to communicate boldness as a brand attribute, the single most obvious, literal, no-brainer way ...

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

Steven H. Stein currently works at Repare Therapeutics, Inc., as Director from 2024, Incyte Corp., as Chief Medical Officer & Executive Vice President from 2016, the University of Pennsylvania, as ...

Google’s logo just got a little bit blurrier ... Google’s “G” took this idea even further, reducing the company’s famous wordmark down to a single letter icon in 2015.

Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...

Zapata-Gomez is currently CFO of Novartis (NOVN.S), opens new tab unit ... the developer of artificial intelligence (AI) chatbot company Replika 5 million euros ($5.64 million) for breaching ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...